Results 1 to 10 of about 9,104 (252)

Trends in Mortality From Novel Psychoactive Substances as "Legal Highs": Gender Differences in Manner of Death and Implications for Risk Differences for Women. [PDF]

Front Psychiatry, 2022
Webb L, Shi X, Goodair C, Cheeta S.
europepmc   +1 more source

Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine. [PDF]

Neuronal Signal, 2021
Sahai MA, Opacka-Juffry J.
europepmc   +1 more source

Piperazine Abuse and Psychosis: A Systematic Review of the Literature

Psychiatry International
Background: Piperazines, synthetic compounds known for their stimulant and hallucinogenic effects, have gained prominence among novel psychoactive substances (NPS) and are frequently associated with adverse psychiatric outcomes, including psychosis ...
Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Clara Cavallotto, John M. Corkery, Livia Miotti, Mauro Pettorruso, Giovanni Martinotti, Fabrizio Schifano   +9 more
doaj   +1 more source

Development and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood. [PDF]

Drug Test Anal, 2022
Giorgetti A, Barone R, Pelletti G, Garagnani M, Pascali J, Haschimi B, Auwärter V.   +6 more
europepmc   +1 more source

Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances. [PDF]

Int J Mol Sci, 2021
Sogos V, Caria P, Porcedda C, Mostallino R, Piras F, Miliano C, De Luca MA, Castelli MP.   +7 more
europepmc   +1 more source

Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes

Brain Sciences
Background: Synthetic cannabinoid receptor agonists (SCRAs, commercially known as “Spice”) have become a leading cause of substance-induced psychosis worldwide.
Alessio Mosca, Stefania Chiappini, Andrea Miuli, Clara Cavallotto, Mauro Pettorruso, Giovanni Martinotti, Fabrizio Schifano   +6 more
doaj   +1 more source

Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures. [PDF]

Int J Drug Policy, 2021
Barenholtz E, Krotulski AJ, Morris P, Fitzgerald ND, Le A, Papsun DM, Logan BK, Hahn WE, Goldberger BA, Cottler LB, Palamar JJ.   +10 more
europepmc   +1 more source

Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach

Brain Sciences
Glucagon-like peptide-1 (GLP-1) is involved in a range of central and peripheral pathways related to appetitive behavior. Hence, this study explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on substance and behavioral ...
Davide Arillotta, Giuseppe Floresta, G. Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano   +6 more
doaj   +1 more source

Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review

Frontiers in Psychiatry
BackgroundMethylphenidate (MPH), a central nervous system stimulant primarily prescribed for attention-deficit/hyperactivity disorder (ADHD), has seen increasing rates of misuse and abuse, particularly in patients with dual diagnosis (co-occurring ...
Stefania Chiappini, Pietro Domenico Gramuglia, Alessio Mosca, Clara Cavallotto, Andrea Miuli, John Martin Corkery, Amira Guirguis, Fabrizio Schifano, Giovanni Martinotti   +8 more
doaj   +1 more source

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications. [PDF]

Life (Basel), 2021
Giorgetti A, Pascali JP, Fais P, Pelletti G, Gabbin A, Franchetti G, Cecchetto G, Viel G.   +7 more
europepmc   +1 more source